טוען...
Dietary Care for ADPKD Patients: Current Status and Future Directions
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic nephropathy, and tolvaptan is the only therapy available. However, tolvaptan slows but does not stop disease progression, is marred by polyuria, and most patients worldwide lack access. This and recent preclinical resear...
שמור ב:
| הוצא לאור ב: | Nutrients |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683072/ https://ncbi.nlm.nih.gov/pubmed/31336917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu11071576 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|